m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis

J Biol Chem. 2022 Feb;298(2):101563. doi: 10.1016/j.jbc.2022.101563. Epub 2022 Jan 6.

Abstract

The cytidine deaminase APOBEC3B (A3B) is an endogenous inducer of somatic mutations and causes chromosomal instability by converting cytosine to uracil in single-stranded DNA. Therefore, identification of factors and mechanisms that mediate A3B expression will be helpful for developing therapeutic approaches to decrease DNA mutagenesis. Arsenic (As) is one well-known mutagen and carcinogen, but the mechanisms by which it induces mutations have not been fully elucidated. Herein, we show that A3B is upregulated and required for As-induced DNA damage and mutagenesis. We found that As treatment causes a decrease of N6-methyladenosine (m6A) modification near the stop codon of A3B, consequently increasing the stability of A3B mRNA. We further reveal that the demethylase FTO is responsible for As-reduced m6A modification of A3B, leading to increased A3B expression and DNA mutation rates in a manner dependent on the m6A reader YTHDF2. Our in vivo data also confirm that A3B is a downstream target of FTO in As-exposed lung tissues. In addition, FTO protein is highly expressed and positively correlates with the protein levels of A3B in tumor samples from human non-small cell lung cancer patients. These findings indicate a previously unrecognized role of A3B in As-triggered somatic mutation and might open new avenues to reduce DNA mutagenesis by targeting the FTO/m6A axis.

Keywords: APOBEC3B; FTO; arsenic; m6A modification; mutagenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / genetics
  • Adenosine / metabolism
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO* / genetics
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO* / metabolism
  • Arsenic* / toxicity
  • Carcinoma, Non-Small-Cell Lung* / chemically induced
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Cytidine Deaminase* / genetics
  • Cytidine Deaminase* / metabolism
  • Demethylation / drug effects
  • Humans
  • Lung Neoplasms*
  • Minor Histocompatibility Antigens* / genetics
  • Minor Histocompatibility Antigens* / metabolism
  • Mutagenesis
  • RNA, Messenger* / genetics
  • RNA, Messenger* / metabolism

Substances

  • Minor Histocompatibility Antigens
  • RNA, Messenger
  • N-methyladenosine
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • FTO protein, human
  • APOBEC3B protein, human
  • Cytidine Deaminase
  • Adenosine
  • Arsenic